WS
MBII

Wedbush Securities’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Wedbush Securities’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-37,129
Closed -$45K – 1027
2020
Q3 		$45K Buy
+37,129
New +$45.1K ﹤0.01% 894

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wedbush Securities's MBII Position: Q4 2020 in Review

Wedbush Securities sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2020, closing a stake of 37,129 shares — an estimated $45K sold.

Wedbush Securities first reported a position in MBII in Q3 2020 and held it in 1 quarter. The position peaked at $45K in Q3 2020. 62 funds tracked by Wall St. Rank hold MBII as of Q4 2020.

  • Wedbush Securities reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2020 after selling out during the quarter.
  • Wedbush Securities sold 37,129 Marrone Bio Innovations, Inc. shares in Q4 2020, an estimated $45K.
  • Wedbush Securities first reported a position in Marrone Bio Innovations, Inc. in Q3 2020 and held it in 1 quarter.
  • Wedbush Securities's Marrone Bio Innovations, Inc. position peaked at $45K in Q3 2020.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.